Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Sell
42
AONC Quote, Financials, Valuation and Earnings
Last price:
$11.12
Seasonality move
:
-1.35%
Day range:
$11.12 - $11.12
52-week range:
$4.04 - $14.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.13x
P/B ratio:
--
Volume:
--
Avg. volume:
1.7K
1-year change:
164.76%
Market cap:
$325.2M
Revenue:
$1.8B
EPS (TTM):
-$2.27
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, American Oncology Network, Inc. has -- downside to fair value with a price target of -- per share.
AONC vs. S&P 500
-
Over the past 5 trading days, American Oncology Network, Inc. has underperformed the S&P 500 by -14.73% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
American Oncology Network, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
American Oncology Network, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter American Oncology Network, Inc. reported revenues of $470.3M.
Earnings Growth
-
American Oncology Network, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter American Oncology Network, Inc. reported earnings per share of -$0.19.
Enterprise value:
557.6M
EV / Invested capital:
--
Price / LTM sales:
0.13x
EV / EBIT:
--
EV / Revenue:
0.32x
PEG ratio (5yr expected):
-24.09x
EV / Free cash flow:
-21.53x
Price / Operating cash flow:
2.15x
Enterprise value / EBITDA:
169.99x
Gross Profit (TTM):
$83.9M
Return On Assets:
-2.24%
Net Income Margin (TTM):
-0.57%
Return On Equity:
-13.79%
Return On Invested Capital:
-6%
Operating Margin:
0.38%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $597.7M | $1.3B | $1.8B | $324.2M | $490.9M | |
| Gross Profit | $52.5M | $70M | $98.5M | $4.4M | $37M | |
| Operating Income | $12.1M | -$17.9M | -$16.1M | -$19.3M | $8.3M | |
| EBITDA | $8.9M | -$1.2M | $3.3M | -$15.1M | $13.9M | |
| Diluted EPS | $0.13 | -$1.37 | -$1.38 | -$0.76 | -$0.00 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $1.3M | $242M | $277.8M | $331.5M | |
| Total Assets | $9.6K | $334.9M | $326.2M | $374.5M | $470.3M | |
| Current Liabilities | $10.4K | $1M | $140.9M | $169M | $216.8M | |
| Total Liabilities | $10.4K | $22.3M | $264.2M | $303.7M | $362.3M | |
| Total Equity | -$800 | $312.6M | $62M | $70.7M | $108M | |
| Total Debt | -- | -- | $119.6M | $126.2M | $143.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$6.8M | -$18.1M | -$4.9M | -$12M | $11.9M | |
| Cash From Investing | -$14M | -$35.4M | -$2.4M | -$10.9M | -$17.2M | |
| Cash From Financing | $15.3M | $55.1M | $41.7M | -$295K | $48.7M | |
| Free Cash Flow | -$14M | -$30.4M | -$25.9M | -$14.7M | $5.6M | |
AONC
Sector
Market Cap
$325.2M
$28.5M
Price % of 52-Week High
78.04%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
-34.6%
-1.33%
1-Year Price Total Return
164.76%
-20.32%
Beta (5-Year)
--
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$11.48
200-day SMA
Buy
Level
$8.99
Bollinger Bands (100)
Buy
Level
9.22 - 11.58
Chaikin Money Flow
Sell
Level
-5.8M
20-day SMA
Sell
Level
$11.33
Relative Strength Index (RSI14)
Buy
Level
51.74
ADX Line
Sell
Level
26.69
Williams %R
Neutral
Level
-46.0912
50-day SMA
Buy
Level
$9.90
MACD (12, 26)
Buy
Level
0.37
25-day Aroon Oscillator
Sell
Level
-8
On Balance Volume
Neutral
Level
19M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.9522)
Sell
CA Score
(Annual)
Level (-1.7175)
Sell
Beneish M-Score
(Annual)
Level (-1.7936)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (3.1781)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
American Oncology Network, Inc. engages in the provision of community-based oncology management. The firm provides various services to patients, including laboratory services for routine and specialized testing, in-house professional and technical pathology services with pathology reports, in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance, and care management support services, including nutrition guidance. The company was founded in 2018 and is headquartered in Fort Myers, FL.
Stock Forecast FAQ
In the current month, AONC has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AONC average analyst price target in the past 3 months is --.
-
Where Will American Oncology Network, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that American Oncology Network, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About American Oncology Network, Inc.?
Analysts are divided on their view about American Oncology Network, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that American Oncology Network, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is American Oncology Network, Inc.'s Price Target?
The price target for American Oncology Network, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is AONC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for American Oncology Network, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of AONC?
You can purchase shares of American Oncology Network, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase American Oncology Network, Inc. shares.
-
What Is The American Oncology Network, Inc. Share Price Today?
American Oncology Network, Inc. was last trading at $11.12 per share. This represents the most recent stock quote for American Oncology Network, Inc.. Yesterday, American Oncology Network, Inc. closed at $11.12 per share.
-
How To Buy American Oncology Network, Inc. Stock Online?
In order to purchase American Oncology Network, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get AONC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AONC
Sector
P/E ratio
--
23.75x
PEG ratio
-24.09x
-0.01x
P/B ratio
--
1.83x
Price / LTM sales
0.13x
1.60x
Growth Metrics
AONC
Sector
Revenue growth
39.84%
4.85%
Earnings growth
--
11.11%
Revenue (5-year growth)
--
6.45%
Earnings forecast
--
-$0.20
Profitability
AONC
Sector
Profitability FY 2024
$98.5M
$3.6M
Return on invested capital
-6%
-30.98%
Return on assets
-2.24%
-27.62%
Return on equity
-13.79%
-36.69%
Earnings Date
Last Earnings Date
Aug
18
Next Earnings Date
Dec
8
Estimated Next Earnings Date
Mar
9
Balance Sheet
AONC
Sector
Total cash
$19.4M
$27.2M
Short term investments
$9.8M
$25.7M
Total assets
$470.3M
$79.7M
Long term debt
$91.4M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
